0001209191-16-149265.txt : 20161110
0001209191-16-149265.hdr.sgml : 20161110
20161110135339
ACCESSION NUMBER: 0001209191-16-149265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161109
FILED AS OF DATE: 20161110
DATE AS OF CHANGE: 20161110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jensen Peder
CENTRAL INDEX KEY: 0001518724
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 161987241
MAIL ADDRESS:
STREET 1: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-11-09
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001518724
Jensen Peder
TWO CORPORATE DRIVE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Common Stock
2016-11-09
4
M
0
4065
5.54
A
4065
D
Common Stock
2016-11-09
4
M
0
4065
7.26
A
8130
D
Common Stock
2016-11-09
4
S
0
8130
55.30
D
0
D
Stock Option (right to buy)
5.54
2016-11-09
4
M
0
4065
0.00
A
2022-07-10
Common Stock
4065
0
D
Stock Option (right to buy)
7.26
2016-11-09
4
M
0
4065
0.00
A
2023-07-18
Common Stock
4065
0
D
The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on April 5, 2016.
This option is fully vested and immediately exercisable.
/s/ Francis Sarena, Attorney-in-fact
2016-11-09